Public market insider buying at Wesana Health Holdings (WESA)

Public market insider buying at Wesana Health Holdings (C:WESA)

The K2 Principal Fund L.P., a 10% Holder, acquired 119,300 Common Shares on a direct ownership basis at prices ranging from $1.139 to $1.540 between January 12th, 2022 and January 14th, 2022. This represents a $138,460 investment into the company's shares and an account share holdings change of 5.8%.

Wesana Health Holdings is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma. Wesana Health Holdings Inc. (WESA) has below median officer and director direct ownership compared to its micro-cap peers in the market, based on our estimate using SEDI data. According to recent regulatory filings, one insider has invested a total amount of $138,460.